Healthcare [ 13/13 ] | Medical Devices [ 113/164 ]
NASDAQ | Common Stock
electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally.
The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania.
It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance.
In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.
Reported date | EPSChange YoY | EstimateSurprise |
---|---|---|
May 8, 24 | -0.52 Increased by +58.06% | -0.62 Increased by +16.13% |
Mar 13, 24 | -0.61 Increased by +50.00% | -0.61 |
Nov 8, 23 | -0.68 Increased by +43.33% | -0.70 Increased by +2.86% |
Aug 9, 23 | -1.03 Increased by +14.17% | -0.96 Decreased by -7.29% |
May 3, 23 | -1.24 Decreased by -3.33% | -1.00 Decreased by -24.00% |
Mar 8, 23 | -1.22 Decreased by -16.19% | -1.12 Decreased by -8.93% |
Nov 3, 22 | -1.20 Decreased by -33.33% | -1.08 Decreased by -11.11% |
Aug 4, 22 | -1.20 Decreased by -33.33% | -1.08 Decreased by -11.11% |
Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
---|---|---|---|
Dec 31, 23 | 5.19 M Increased by +102.77% | -4.03 M Increased by +30.36% | Decreased by -77.67% Increased by +65.66% |
Sep 30, 23 | 4.51 M Increased by +128.14% | -4.03 M Increased by +24.64% | Decreased by -89.44% Increased by +66.97% |
Jun 30, 23 | 3.55 M Increased by +64.63% | -4.90 M Increased by +8.13% | Decreased by -138.07% Increased by +44.20% |
Mar 31, 23 | 2.78 M Increased by +46.39% | -5.87 M Decreased by -5.09% | Decreased by -211.04% Increased by +28.22% |
Dec 31, 22 | 2.56 M Increased by +71.72% | -5.79 M Decreased by -17.05% | Decreased by -226.17% Increased by +31.84% |
Sep 30, 22 | 1.98 M Increased by +32.88% | -5.35 M Decreased by -33.96% | Decreased by -270.75% Decreased by -0.82% |
Jun 30, 22 | 2.16 M Increased by +69.91% | -5.34 M Decreased by -84.43% | Decreased by -247.43% Decreased by -8.54% |
Mar 31, 22 | 1.90 M Increased by +57.74% | -5.58 M Decreased by -3.70% | Decreased by -294.00% Increased by +34.26% |